The Anticancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved among Structurally Diverse Hsp90 Inhibitors | Journal of Proteome Research
Sponsor Novartis Generic Drug Name Alpelisib/BYL719 and AUY922 Trial Indication(s) Advanced or metastatic gastric cancer (GC) ca
Luminespib (VER-52296) | HSP90 Inhibitor | MedChemExpress
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. - Abstract - Europe PMC
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models | Breast Cancer Research | Full Text
HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice | ACS Chemical Neuroscience
Exploring the inhibitory mechanism of resorcinylic isoxazole amine NVP- AUY922 towards the discovery of potential heat shock protein 90 (Hsp90) inhibitors - ScienceDirect
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Luminespib - Wikipedia
Luminespib - an overview | ScienceDirect Topics
Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells | Anticancer Research
![PDF] Ganetespib: research and clinical development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25a520c1fa08e8bd4ed3d065bbaddb983055dc78/2-Table1-1.png "PDF] Ganetespib: research and clinical development | Semantic Scholar")
PDF] Ganetespib: research and clinical development | Semantic Scholar
Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer | Anticancer Research
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer - ScienceDirect
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis | Cell Death Discovery
Frontiers | Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
In vitro sensitivity to NVP-AUY922. Forty-one cell lines with IC50 (A)... | Download Scientific Diagram
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP‐AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma - Seggewiss‐Bernhardt - 2015 - Cancer -
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
